Alcon Acquires Aurion Biotech to Advance Cell Therapy for Corneal Diseases 3 min read Business Alcon Acquires Aurion Biotech to Advance Cell Therapy for Corneal Diseases The Scientific Reporters March 29, 2025 Introduction In a significant move within the ophthalmology sector, Alcon, a global leader in eye care, has... Read More Read more about Alcon Acquires Aurion Biotech to Advance Cell Therapy for Corneal Diseases
